Cite
MLA Citation
Christoph U. Correll et al.. “Safety and efficacy of KarXT (Xanomeline Trospium) in Schizophrenia in the Phase 3, Randomized, Double-Blind, Placebo-Controlled EMERGENT-2 Trial.” CNS spectrums, vol. 28, 2023, p. 220. http://access.bl.uk/ark:/81055/vdc_100184055734.0x00002b